Ambler Class A Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp. in Canadian Hospitals
Open Access
- 1 April 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (4), 1204-1214
- https://doi.org/10.1128/aac.48.4.1204-1214.2004
Abstract
This report describes a study carried out to gain baseline information on the molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in Canada. A total of 29,323 E. coli and 5,156 Klebsiella sp. isolates were screened at 12 participating sites. Of these, 505 clinically significant, nonrepeat isolates displaying reduced susceptibility to the NCCLS-recommended beta-lactams were submitted to a central laboratory over a 1-year period ending on 30 September 2000. A total of 116 isolates were confirmed to be ESBL producers. PCR and sequence analysis revealed the presence of TEM-11 (n = 1), TEM-12 (n = 1), TEM-29 (n = 1), TEM-52 (n = 4), CTX-M-13 (n = 1), CTX-M-14 (n = 15), CTX-M-15 (n = 11), SHV-2 (n = 2), SHV-2a (n = 12), SHV-5 (n = 6), SHV-12 (n = 45), and SHV-30 (n = 2). Five novel beta-lactamases were identified and designated TEM-115 (n = 2), TEM-120 (n = 1), SHV-40 (n = 2), SHV-41 (n = 4), and SHV-42 (n = 1). In addition, no molecular mechanism was identified for five isolates displaying an ESBL phenotype. Macrorestriction analysis of all ESBL isolates was conducted, as was restriction fragment length polymorphism analysis of plasmids harboring ESBLs. Although a “clonal” distribution of isolates was observed at some individual sites, there was very little evidence suggesting intrahospital spread. In addition, examples of identical or closely related plasmids that were identified at geographically distinct sites across Canada are given. However, there was considerable diversity with respect to plasmid types observed.Keywords
This publication has 46 references indexed in Scilit:
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Diversity of SHV and TEM β-Lactamases in Klebsiella pneumoniae : Gene Evolution in Northern Taiwan and Two Novel β-Lactamases, SHV-25 and SHV-26Antimicrobial Agents and Chemotherapy, 2001
- Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1FEMS Microbiology Letters, 2001
- PulseNet: The Molecular Subtyping Network for Foodborne Bacterial Disease Surveillance, United StatesEmerging Infectious Diseases, 2001
- PulseNet: The Molecular Subtyping Network for Foodborne Bacterial Disease Surveillance, United StatesEmerging Infectious Diseases, 2001
- SHV-14, a Novel β-Lactamase Variant in Klebsiella pneumoniae Isolates from Nijmegen, The NetherlandsAntimicrobial Agents and Chemotherapy, 2001
- Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum β-lactamaseFEMS Microbiology Letters, 1999
- Clinical Strategies for Serious Infection: A North American PerspectiveDiagnostic Microbiology and Infectious Disease, 1998
- Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E testEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamasesFEMS Microbiology Letters, 1995